-
Diagnostics World | AI took center stage in diagnostics stories in 2023, assessing breast cancer prognoses and helping identify biomarkers. But it’s also under the microscope as researchers seek to validate “black box” AI findings. Plus: news from Illumina and a call for more diverse cystic fibrosis screening. Here’s a look at the top stories from Diagnostics World as well as thought leaders in the industry.
Jan 4, 2024
-
Diagnostics World | To kick off the New Year, we spoke with leaders and experts in the Diagnostic World community about their insights and predictions for 2024.
Jan 3, 2024
-
Diagnostics World | PerkinElmer has acquired Covaris; Revvity has launched its EONIS Q system, which can help test for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
Dec 28, 2023
-
Diagnostics World | PCORI approves funding awards meant to fill evidence gaps related to multiple different illnesses; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Pepper Bio, the “Google Maps for drug discovery,” plans to accelerate its transomics platform capabilities, fueling the pipeline for more accurate and accessible drug discovery; and more.
Dec 27, 2023
-
Diagnostics World | There is mounting evidence that epigenetics—the molecular processes that influence how genes are expressed—is an equally if not more important driver of disease conditions and phenotypic differences than genetics. That means that accelerating the shift from reactionary medicine to preventive care is going to require biomarkers of these heritable and reversible changes.
Dec 21, 2023